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Abstract
Chronic Obstructive Pulmonary Disease (COPD) is characterized by airspace enlargement and peribronchial lymphoid
follicles; however, the immunological mechanisms leading to these pathologic changes remain undefined. Here we show
that cigarette smoke is a selective adjuvant that augments in vitro and in vivo Th17, but not Th1, cell differentiation via the
aryl hydrocarbon receptor. Smoke exposed IL-17RA
2/2 mice failed to induce CCL2 and MMP12 compared to WT mice.
Remarkably, in contrast to WT mice, IL-17RA
2/2 mice failed to develop emphysema after 6 months of cigarette smoke
exposure. Taken together, these data demonstrate that cigarette smoke is a potent Th17 adjuvant and that IL-17RA
signaling is required for chemokine expression necessary for MMP12 induction and tissue emphysema.
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Introduction
Chronic obstructive pulmonary disease (COPD) accounts for 5–
10% of all deaths globally and it is estimated that 80 million people
currently suffer with COPD of varying degrees [1]. COPD is
attributed to persistent exposure to noxious gases and particulates,
and is most often associated with cigarette smoke. This exposure
induces a chronic inflammatory state in which there is mucus
hypersecretion and the formation of airway associated lymphoid
follicles [1–3]. This leads to inflammatory obstruction of the upper
and lower airways and destruction of parenchymal structure
(emphysema), leading to chronic, progressive decrease in airflow
[2,3].
T lymphocytes are a prominent cell type in the COPD
inflammatory milieu. CD4
+ and CD8
+ T cells are found in both
airways and parenchyma during COPD and increases in these
populations is associated with a greater severity of disease and
worsening prognosis [3,4]. COPD-associated T cells produce Th1
[5–7] and Th2 cytokines [8]. Recently, IL-17 producing T cells
known as Th17 cells have been identified in lungs from COPD
patients [4,9], suggesting an important role for this cytokine.
T helper 17 (Th17) cells are a critical component of the adaptive
immune response, but have also been implicated in chronic
inflammatory diseases and autoimmune diseases [10]. Naive T
cells differentiate into Th17 cells through co-exposure to IL-6 and
TGF-b, both of which are present during COPD. It has also been
shown that the aryl hydrocarbon receptor (AhR), which is
activated by cigarette smoke, may have a role in promoting the
Th17 response and expression of IL-22 [11]. Moreover, IL-17A
was recently detected in sputum from patients with COPD and
this correlated with airflow obstruction [12,13]. Interestingly,
tobacco smoke is associated with autoimmune diseases, particu-
larly systemic lupus erythematosus [14], rheumatoid arthritis [15]
and inflammatory bowel diseases [16]. While these studies
demonstrate the presence of IL-17 in COPD, whether Th17 cells
or their cytokine products contribute to pathology remains
unknown.
In the study, we show that cigarette smoke is a selective adjuvant
that augments mucosal Th17 but not Th1 cell differentiation in vitro
and in vivo in part by an aryl hydrocarbon receptor-dependent
mechanism. RNA sequencing analysis of human bronchial epithe-
lium shows that IL-17 and IL-22 can induce MMP3 and MMP12,
the latter gene implicated in cigarette smoke-induced emphysema
[17]. Mice lacking IL-17RA showed substantially reduced macro-
phage recruitment, CCL2 and CXCL10 in bronchoalveolar lavage
after 6 months of smoke exposure. This reduced macrophage
recruitment was associated with reduced expression of MMP12
transcripts in the lung. Remarkably, in contrast to WT mice, IL-
17RA
2/2 failed to develop emphysema after 6 months of cigarette
smoke exposure. Taken together these data demonstrate that
cigarette smoke is a potent Th17 adjuvant and that IL-17RA
signaling is required for the elaboration of CCL2, macrophage
recruitment and tissue emphysema. These data suggest a novel
immune pathway that may be a target of intervention for COPD.
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Cigarette Smoke is a Th17 Adjuvant
Cigarette smoke is a complex mixture of gaseous and particulate
materials that contains Ahr ligands as well as LPS [18,19] and has
been shown to induce IL-23 in macrophages [20]. To examine if
cigarette smoke affects Th17 differentiation, we purified naı ¨ve CD4
+
and CD8
+ T-cells from the spleens of C57BL/6 miceand performed
T-cell differentiation under Th17 polarizing conditions in the
presence or absence of cigarette smoke extract (CSE). The addition
of 0.5% CSE significantly increased the percentage of CD4 and
CD8 T-cells that stained positive for IL-17 (Figure 1A). Moreover,
Luminex analysis of cell supernatants also showed that these cells
produce more secreted IL-17 in culture (Figure 1B). CSE also
increased IL-22 expression during Th17 polarization in RPMI 1640
media which lacks Ahr ligands [21] (Figure 1C). As a positivecontrol
the Ahr ligand FICZ also stimulated IL-22 production. Addition of
CSE substantially increased Rorc, a critical transcription factor for
Th17 differentiation, inaddition toIl17aand Il22(Figure 1D).Again
FICZ also increased transcripts for Il17a and Il22 in this culture
system(Figure1D).NeitherCSEnorFICZaffectedtheexpressionof
Foxp3. However FICZ suppressed Tbx21 expression and both FICZ
and CSE suppressed expression of Gata3 (Figure 1D).
We next examined if CSE could serve as a Th17 adjuvant in
vivo. For these studies we administered ovalbumin (OVA)
intratracheally to OVA specific T-cell receptor transgenic (OT-
II) mice with or without CSE. Sevens days later, Th priming was
assessed in lung and mediastinal lymph nodes by FACS. OVA
alone induced modest numbers of Th17 and Th1 cells in both the
lung and mediastinal lymph node tissues (Figure 2A). However,
the addition of CSE induced substantially greater Th17 cells at
both sites (Figure 2A). The effect was greatest in lung tissue.
Interestingly, CSE had no effect on Th1 priming. Analysis of
transcripts in lung tissue by quantitative real time PCR also
showed greater Il17a transcription and no effect on Ifng transcripts
in mice that had been given OVA with CSE (Figure 2B).
As CSEcontains aryl hydrocarbon receptorligands, we testedthe
requirement for Ahr in CSE mediated Th17 in vitro. Naı ¨ve splenic
CD4 T-cells from Ahr
2/2 mice could be differentiated into Th17
cellsinthepresence ofTGF-bandIL-6;however,incontrasttoWT
cells (Figure 1), CD4 T-cells from Ahr
2/2 mice failed to show
increased Th17 differentiation with CSE or FICZ (Figure 3).
RNA-seq analysis Human Lung Epithelial cells
Polarized human bronchial epithelial (HBE) cells express IL-
17RA on their basolateral surface, and the induction of G-CSF and
CXCL1 by IL-17 only occurs when the ligand is applied
basolaterally and not apically [22,23]. Previously, a subset of basal
cells expressing aquaporin 3 (AQP3) were found to have multi-
potential differentiation characteristics in xenograft assays [23–25].
To determine if expression of IL-17RA, IL-17RC, and IL-22R was
localized toAQP3
+cells,weused flow cytometry.Approximately9–
15 percent of AQP3
2 cells stained positive for IL-17RA, IL-17RC
or IL-22R (Table 1). By comparison, a significantly higher
percentage of AQP3
+ cells expressed these receptors, 26–32 percent
compared to the AQP3- population, demonstrating preferential
expression within the putative multi-potential population.
Previously, we showed that IL-22 increases the clonogenic
potential of HBE cells [22], and microarray studies demonstrated
an additive induction of CSF3 and CXCL1 among other genes
following stimulation with IL-22 plus IL-17 compared to IL-17
alone [22]. Using a false discovery rate (FDR) of p,0.05,
treatment with IL-22 alone induced fewer than 7 genes [22].
We postulated that the paucity of genes regulated by IL-22 could
be due to a limitation of the hybridization based array approach,
and thus we performed polyA+ RNA deep sequencing of three
HBE donors treated with IL-17, IL-22, or both. Qseq software
(Lasergene) was used to determine the relative transcript
abundance. In addition, we analyzed samples that had been
hybridized on Affymetrix Hu-133 arrays. Relative gene expression
assayed by normalized Affymetrix signal intensity was then plotted
versus the relative transcript abundance obtained by RNA
sequencing (Fig. 4A; x-axis versus y-axis, respectively). When
relative transcript abundance is high, the two platforms have a
linear relationship with one another. However, for genes that have
lower transcript abundance, the Affymetrix hybridization based
methodology reaches an asymptotic relationship (with relative
gene expression levels of approximately 7 or lower). In contrast,
RNAseq continued to have broad dynamic range (Figure 4A),
demonstrating a much higher sensitivity than microarray plat-
forms.
We next determined if IL-17 and/or IL-22 induces genes that
are involved in the pathogenesis of COPD. Specifically, we
analyzed expression of matrix metalloproteinases (MMPs) that can
mediate tissue degradation, and CCL2 ligands that mediate
macrophage recruitment to the lung [17]. The combination of IL-
17 plus IL-22 increased the expression of MMP12, MMP15,
MMP10 and MMP3 in all three HBE donors samples (Figure 4B).
These changes in MMP expression were not detectable using
hybridization microarray technology (data not shown). We also
observed a significant reduction in tissue inhibitor of metallopro-
teinases (TIMP) 2 expression in HBE cells treated with IL-17 and
IL-22. Notably, dual cytokine treatment resulted in a significant
induction of CCL2 (Figure 4C), but not CCL3 or CCL5 (data not
shown). The up-regulation of Ccl2, Mmp3 and Mmp12 were
confirmed by real-time RT-PCR (Figure 4D), demonstrating a
correlation between Th17 cytokines and the upregulation of genes
involved in COPD.
IL-17RA regulates expression of CCL2, Mmp9, Mmp12,
and the development of emphysema in vivo
To determine if IL-17RA was required for expression of the
genes identified by our RNAseq in vivo after cigarette smoke
exposure, we analyzed expression of these genes by quantitative
real time PCR in WT or IL-17RA
2/2 mice exposed cigarette
smoke for 6 months as previously described [17]. IL-17 protein
levels were significantly elevated in the BAL of mice exposed to
smoke compared to sham controls (Figure 5A). We also noted
similar induction of IL-17 protein in IL-17RA
2/2 mice exposed to
smoke (Figure 5A). Moreover, smoke-exposed IL-17RA KO mice
had significantly lower total cells as well as macrophage numbers
in BAL compared to WT mice (Figure 5B). Reductions in alveolar
macrophage numbers in BAL were associated with a significantly
reduced level of the chemokines CCL2, CCL5, and CXCL10, but
not CXCL1 (Figure 5C). Analysis of MMP expression by
quantitative real time PCR also showed reduced levels of
MMP12 and MMP9 in smoke exposed IL-17RA
2/2 mice
compared to WT mice (Figure 5D). We next examined tissue
emphysema in lungs inflated to 20 cm H2O. Sham exposed mice
showed normal lung architecture (Figure 6A and B) as well as
values for mean alveolar distance that were in the normal range
(Figure 6E). WT smoke exposed mice showed significant airspace
enlargement compared to the sham control (Figure 6C). In
contrast IL-17RA
2/2 mice showed significantly less tissue
emphysema (Figure 6D), which was also associated with a reduced
mean linear intercept (Figure 6E) that approached the level of
sham exposed mice.
IL-17RA and Emphysema
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The development of tissue emphysema due to cigarette smoke
exposure in mice requires macrophages and the expression of
matrix metalloproteinase 12 and 9 [17,26,27]. Interestingly, the
intratracheal administration of CCL2 can augment emphysema
but not in MMP12
2/2 mice [17], suggesting that MMP12 rather
than macrophages per se is critical for emphysema [17]. IL-17 has
been shown to be an important inducer of CCL2, and mice
overexpressing IL-17A or IL-17F show elevated CCL2 in the lung
Figure 1. Cigarette smoke extract enhances in vitro Th17 polarization. Naı ¨ve CD4+ or CD8+T cells from C57BL/6 spleen were activated by
plate bound anti-CD3 and anti-CD28 in the presence of TGF-b, IL-6, anti-IFN-c and anti-IL4. Where indicated, 0.5% CSE or 200nM FICZ were added into
the culture. On day 3, cells were harvested and intracellular cytokines were analyzed by FACS (A, C). Tissue culture supernatants were harvested from
in vitro polarized Th17 cells for secreted IL-17 by Luminex (C, n=5 per group, * denotes p,0.05 compared to vehicle). RNA was extracted from the
same cells for gene expressions analysis by real-time RT-PCR (D, n=5 per group, * denotes p,0.05 compared to vehicle-HBSS).
doi:10.1371/journal.pone.0020333.g001
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immune response in COPD since it has been recently reported
that COPD in humans is associated with the development of
lymphoid follicles in the lung [3]. Moreover, patients with COPD
have evidence of anti-elastin antibodies and Th1 responses,
suggesting an autoimmune component [28]. Furthermore, mice
deficient in CD8
+ T-cells are resistant to cigarette smoke induced
emphysema whereas CD4
+ T-cell deficient mice are not [29].
Recently we have shown that IL-17RA is critical for germinal
center formation in BXD2 mice as well as lymphoid follicles in
mice with EAE [30,31]. These data suggest that IL-17RA may
play a role in lymphoid follicle development as well as other
pathological features in COPD. In further support of this
hypothesis, IL-17 producing cells are increased in the lungs of
patients with COPD [4,32]. Cigarette smoke is a complex mixture
of particulates that contain TLR agonists as well as aryl
hydrocarbon ligands [18,19]. Addition of CSE to T-cells
undergoing Th17 differentiation augmented the percentage of
IL-17 and IL-22 producing cells as well as the transcription factor
Rorc. Importantly, the addition of CSE to OVA significantly
increased the number of Th17 cells in vivo as well. We did not
observe a significant effect on Th1 responses. One mechanism by
which cigarette smoke acts as a Th17 adjuvant is via Ahr, as T-
cells form Ahr
2/2 mice did not show increased Th17 differen-
tiation with CSE or the known Ahr ligand FICZ. Given the fact
that IL-17 over expression increases CCL2 expression, we
hypothesized that IL-17RA
2/2 mice would have reduced
macrophage recruitment and reduced cigarette smoke induced
emphysema. After 6 months of cigarette smoke exposure we found
that IL-17RA was critical for the induction of CCL2, macrophage
recruitment, MMP12 expression, and emphysema in mice. We
also observed a significant reduction of the CCR3 ligand CCL5 in
IL-17RA KO mice and CXCR3 ligands like CXCL10 have also
been shown to induce MMP12 expression in macrophages
[29,33]. Taken together, these data suggest that IL-17RA
expression may be affecting two independent processes that are
required for the development of emphysema, namely macrophage
recruitment via CCL2 and induction of MMP12 by CXCL10.
It is important to note that IL-17RA has at least three ligands
including IL-17A, IL-17F, and IL-25. Both IL-17A and IL-17F
can regulate CCL2 and CXCL10 expression [26,27] and thus the
individual contributions of these two IL-17 family members needs
to be determined. We did not observe increases in IL-25 in this
model (data not shown) or an increase in eosinophils which make
IL-25, and therefore IL-17RB signaling is unlikely to play a
significant role in this phenotype. The specific roles of IL-17A and
IL-17F are being investigated in ongoing studies using specific
knockout mice.
Although the expression of Ahr was required for the effect of CSE
on in vitro Th17 differentiation, other factors such as LPS,
lipopeptides or other activators of innate immunity likely play
critical roles in priming Th17 responses in vivo. For example, smoke
could also activate the inflammasome and processing of IL-1b,
another critical factor in regulating Th17 differentiation [34,35]. We
hypothesize that major target cells of IL-17RA dependent signaling
are epithelial cells, as prior studies using in situ hybridization have
shown they are crucial for IL-17-induced chemokine expression
[22]. IL-17 regulates CCL2 in both human and mouse lung
epithelium, and we hypothesize that CCL2 is required for the
increased number of macrophages in smoke exposed WT mice as
opposed to IL-17RA
2/2 mice. Mechanistically, it has been shown
that IL-17 stabilizes the half-life of chemokine mRNAs [36], and this
may explain the increase in transcripts for CCL2. In summary,
cigarette smoke is a selective Th17 adjuvant in part via the Ahr
receptor. This may also in part explain the known association of
tobacco smoking and autoimmune diseases such as systemic lupus
erythematosus [14], rheumatoid arthritis [15] and inflammatory
bowel diseases [16]. Invivo cigarette smoke induces CCL2inthe lung
in an IL-17RA dependent manner, and IL-17RA is essential for
smoke induced macrophage recruitment and emphysema. These
data demonstrate that antagonism of the Th17 pathway may be a
therapeutic target in COPD.
Figure 2. Cigarette smoke extract enhances Th17 differentiation in vivo. (A) OTII mice were given 50 mg OVA in 50 mL HBSS or CSE
intratracheally on day 0, day 7 and sacrificed on day 14. Single cell suspensions harvested from lung digest and mediastinal lymph nodes were re-
stimulated with PMA and ionomycin in the presence of Golgi-plug for 5h, intracellular cytokines were analyzed by FACS (A). Gene expression in lung
tissue was analyzed by real-time RT-PCR (B, n=5 per group, * denotes p,0.05 compared to OVA alone).
doi:10.1371/journal.pone.0020333.g002
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Ethics Statement
All procedures were performed according to the University of
Pittsburgh and LSU Health Sciences Center IACUC guidelines
(protocols 168 and 2660 respectively). Studies with primary
human bronchial epithelial cells were approved by the University
of Pittsburgh IRB, protocol number IRB970946.
Mice and intratrachel administrations
C57BL/6 (B6), B6.Cg-Tg(TcraTcrb)425Cbn/J (OTII) mice
were purchased from The Jackson Laboratory. 50 mg Ovalbumin
(Sigma) was given to isoflurane anesthetized mice in sterile PBS
(50 ml) by oropharyngeal aspiration-tongue pull technique together
with 50 mL HBSS or 100% cigarette smoke extract. Il17Ra
2/2
mice on the B6 background were provided by Amgen (Seattle,
WA). AhR KO mice were obtained from Dr Frank Gonzalez
(National Cancer Institute, Bethesda, MD).
Preparation of CSE
Research-grade cigarettes (1R3F) with a filter from the Kentucky
Tobacco Research and Development Center at the University of
Kentucky (Lexington, KY) were smoked to 0.5 cm above the filter in a
fume hood, using a modification of the method developed by Carp and
Janoff [37]. CSE was prepared by bubbling smoke from 8 cigarettes
into 10 ml of HBSS at a rate of 1 cigarette/min. The pH of the HBSS
was adjusted to 7.4 and the medium was sterile filtered with a 0.45 um
filter (Corning). The 10 ml HBSS was then used as 100% CSE.
In vitro differentiation of Th17 cells
CD4+ T cells from the spleens and lymph nodes of B6 mice
were enriched by negative selection using magnetic beads
Figure 3. Requirement of AhR for enhanced in vitro Th17 polarization by cigarette smoke extract. Naı ¨ve CD4+ T cells from Ahr2/2
spleen were activated by plated bounded anti-CD3 and anti-CD28 in the presence of TGF-b, IL-6, anti-IFN-c and anti-IL4. Where indicated, 0.5% CSE or
200 nM FICZ were added into the culture. On day 3, cells were harvested and intracellular cytokines were analyzed by FACS (A). Tissue culture
supernatants were harvested from in vitro polarized Th17 cells from Ahr2/2 spleen for secreted IL-17 by Luminex and IL-22 by ELISA (B, n=5 per
group, * denotes p,0.05 compared to vehicle-HBSS).
doi:10.1371/journal.pone.0020333.g003
Table 1. Percent positivity of IL-17R and IL-22R expression on
HBE cells gated on AQP3- versus AQP3+ cells.
AQP3- AQP3+
% pos. IL-17RA 1563.2 2663.8*
% pos. IL-17RC 1161.9 3264.3*
% pos. IL-22R 961.6 2963.4*
*denotes p,0.05 compared to AQP3- gates. n=3 donors, Mann-Whitney
comparison.
Primary HBE cells from 3 separate donors were stained anti-AQP3, anti-IL22R,
anti-IL-17RA, or anti-IL-17RC. Cells were gates on AQP3 and the percentage that
stained for IL-17RA, IL-17RC, or IL22R are shown in Table 1 as mean percentages
6 SEM.
doi:10.1371/journal.pone.0020333.t001
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FACSAria (BD Biosciences); purity was consistently .99%. Cells
were activated by plate-bonded anti-CD3 (3 mg/mL) and anti-
CD28 (3 mg/mL) in RPMI medium supplemented with 5 ng/ml
porcineTGF-b, 40 ng/ml rmIL-6, 5 mg/ml anti-IL-4, and 5 mg/
ML anti-IFN-c. Where indicated 0.5% CSE or 200 nM FICZ
(BioMol) were added to the culture. On Day3, tissue culture
supernatants were harvested for secretary cytokine analysis and
cells were harvested for intracellular cytokine analysis.
Isolation of murine lung single cells for ICS
Lungs are isolated and minced with forceps and small scissors
and digested with 1-2 mg/mL Collagenase (Sigma) for 90 min at
37uC. Digested tissues were passed through a sterile 70 mm filter
(BD Falcon) to get a single cell suspension. After washing, the cells
are ready for FACS or in vitro stimulation.
Flow cytometric analysis
In vitro polarized T cells or single cells from mouse lung were
stimulated for 5–6 h with 50 ng/ml PMA (Sigma) and 750 ng/ml
ionomycin (Sigma). After 1 h, 1 mL/mL GolgiStop (BD Pharmin-
gen, San Diego, CA) was added to block cytokine secretion. Cells
were surface stained for 15–30 min at 4uC with anti-CD4 mAb
(RM45; BD Pharmingen, San Diego, CA) in PBS supplemented
with 1% BSA and 0.2% sodium azide. Cells were then fixed and
permeabilized with Cytofix/Cytoperm (BD Pharmingen, San
Diego, CA) and stained intracellularly with anti-IL-17, anti-IL-22
and anti-IFN-c (XMG1.2) (eBioscience, San Diego, CA). Samples
were acquired on a FACSAria or LSR-II flow cytometer and data
analysis was conducted using FlowJo software (Treestar). HBE
cells were stained with anti-AQP3 followed by anti-IL-22R anti-
IL-17RA or anti-IL-17RC (mouse anti human IL-17RC gener-
ously provided by S. Levin, Zymogenetics).
RNA-seq analysis
HBE cells, purchased from Lonza (Walkersville, MD), were
cultured according to Gray and colleagues [38]. Primary human
bronchial epithelial cells were treated with IL-17 (50 ng/mL)
and/or IL-22 (10–50 ng/mL) for 48 h. Total RNA was isolated
using TRIZOL Reagent (Invitrogen; Carlsbad, CA) and RNA
integrity was determined with the Agilent 2100 Bioanalyzer
(Carlsbad, CA). Samples with RINs ranging from 7.6 to 9.9 were
Figure 4. Th17 cytokines induce MMP expression in HBE cells. (A) Primary HBE cells were stimulated with media or a combination of 10/
-50 ng/ml IL-22 and 50 ng/ml of IL-17A for 48 hours (n=3 donors per condition). RNA was harvested and subjected to hybridization on Hu-133 arrays
for RNA sequencing as described in the Methods. Transcript abundance or hybridization intensity was measured on normalized data in Qseq software
(Lasergene). Scatter plot analysis of normalized transcript abundance for Affymetrix (x-axis) and RNA-seq (y-axis) are shown. (B) Relative gene
expression of MMPs and TIMP2 from RNA-seq data. (C) Up-regulation of Ccl2 by IL-17 and IL-22 combination treatment in primary HBE cells as
measured by RNAseq. (D) CCL2, MMP3 and MMP12 gene expression were analyzed by real-time RT-PCR.
doi:10.1371/journal.pone.0020333.g004
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San Diego, CA). Briefly, mRNA was purified from 2–5 ug of total
RNA using Sera-Mag Oligo(dT) Beads, fragmented with
magnesium-catalyzed hydrolysis and reverse transcribed into
cDNA using random primers (Superscript II; Invitrogen). Then,
cDNA underwent end repair with T4 DNA polymerase and
Klenow DNA polymerase, followed by the addition of ‘A’ bases
to the 39 end, and ligation to adaptor oligos. Products from the
ligation were run on a 2 percent agarose gel. A gel slice consisting
of the 200 bp region (+/225 bp) was excised and used as a
template for PCR amplification. The final PCR product was
purified, denatured with 2 N NaOH, and diluted to 10–12 pM
prior to cluster amplification on a single-read flow cell v4, as
outlined in the Single Read Cluster Generation Kit v4 (Illumina).
The flow cell was sequenced on an Illumina Genome Analyzer II
at the LSUHSC Genomics Core facility.
Figure 5. Requirement of IL-17RA for smoke induced lung inflammation. (A) BAL levels of IL-17 after six months of cigarette smoke
exposure (n=5–6 per group, * denotes p,0.05 compared to WT sham). (B) BAL total cells and alveolar macrophage numbers after 6 months of
smoke exposure. (n=5–6 per group, * denotes p,0.05 compared to WT sham) (C) Levels of CCL2, CCL5, CXCL10 and CXCL1 in lung homogenate
after six months of cigarette smoke exposure (n-5–6 per group, * denotes p,0.05 compared to WT sham). (D) Expression of transcripts for MMP12
and MMP9 using RT
2 Profiler PCR Array. The delta Ct values were calculated by individual gene Ct value minus that of the associated housekeeping
gene and expressed as relative gene expression compared to the WT sham group (n-5–6 per group, * denotes p,0.05 compared to WT sham).
doi:10.1371/journal.pone.0020333.g005
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Eight to ten weeks Il17Ra
2/2 female mice and their age, gender
matched non-smoke controls were subjected to two unfiltered
cigarettes per day (University of Kentucky), 5 days per week for 6
months, with the use of a smoking apparatus as previously
described [17]. Mice tolerated smoke exposure without toxicity;
carboxyhemoglobin levels after two cigarettes were 10%. Sham
and non-smoke-exposed age-matched littermates were used as
controls. Here and previously, sham chamber-exposed mice were
equivalent to non-smoke-exposed mice.
Figure 6. Requirement of IL-17RA for emphysema. Representative histological sections of mouse lungs stained with hematoxylin and eosin
after six months of exposure to air (sham exposed) (A,B) or cigarette smoke (C,D) demonstrate C57BL/6 mice develop alveolar enlargement (C) as
opposed to IL-17RA2/2 mice (D). (E) Enlargement of airspaces was quantified using the mean linear intercept method. This method determines the
parenchymal surface area relative to lung volume. An increase in Lm represents an increase in the alveolar space as seen in the WT smoking mice
versus sham air. This increase in Lm was not seen in the IL-17A2/2 mice over sham air controls. All lung tissues were inflated to 25cm water pressure
with neutral buffered formalin. Original magnification: x 50 of representative sections.
doi:10.1371/journal.pone.0020333.g006
IL-17RA and Emphysema
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Mice were anesthetized with Ketamine. A tracheal cannula was
inserted into the upper cervical trachea through a tracheotomy.
The lungs were lavaged with 0.5-ml aliquots of warmed PBS +
0.5 mM EDTA up to 11 ml. The first ml of recovered
bronchoalveolar lavage (BAL) fluid was centrifuged at 500 g and
the supernatant was stored at 280uC for subsequent cytokine
ELISAs. The remaining cell pellet was combined with the other
lavage fluid and analyzed for total cell count followed by
differential cell counts performed in cytospins and stained with
Wright-Giemsa (Baxter McGaw Park).
Measurement of cytokines
Right lung tissue was harvested after BAL and was homoge-
nized for cytokine assay. All cytokines were measured by multiplex
analysis using Luminex (Millipore) on the Bioplex reader (Bio-
Rad).
Morphometry
Following smoke exposure, each mouse was sacrificed and the
lung was inflated by instilling 3% gluteraldehyde in 0.1 mol/L
cacodylate buffer to 25 cm H20 (for 15 minutes), and then ligated
and removed. Inflated lungs were fixed for 48 hours before
embedding in paraffin. Serial sagittal sections were obtained. Mid-
sagittal sections stained with hematoxylin and eosin (H&E) were
used to calculate the mean linear intercepts as previously described
[[17]].
MMP gene expression assay
Mouse extracellular matrix metallopeptidase gene expression
was measured by using RT
2 Profiler PCR Array kit following
manufacturer’s protocol (SABiosiences). Briefly, total lung tissue
was harvested and total RNA was extracted using TRIzol
(Invitrogen). First strand cDNA was synthesized after genomic
DNA was eliminated. cDNA was then used for real-time PCR for
MMPs gene expression using RT
2 Profile PCR Array primer plate
and SYBR green qPCR master mix. The delta Ct values were
calculated by individual gene Ct value minus that of the associated
housekeeping gene.
Statistical Analysis
Comparison between means was performed with analysis of
variance (ANOVA) followed by Fisher’s follow-up testing or by
Mann-Whitney non parametric analysis. p,0.05 was considered
to represent a significant difference.
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